Effectiveness of the current and prior influenza vaccinations in Northern Spain, 2018-2019

Viral Infections, Non-HIV

Influenza vaccine effectiveness against hospitalization with laboratory-confirmed influenza in Greece: A pooled analysis across six seasons, 2013-2014 to 2018-2019

Vaccine.

Mouratidou E, Lambrou A, Andreopoulou A, Gioula G, Exindari M, Kossyvakis A, Pogka V, Mentis A, Georgakopoulou T, Lytras T

doi: 10.1016/j.vaccine.2020.01.083.

Further Publications Infectiology

Relative Effectiveness of the Cell-Derived Inactivated Quadrivalent Influenza Vaccine Versus Egg-Derived Inactivated Quadrivalent Influenza Vaccines in Preventing Influenza-Related Medical Encounters During the 2018-2019 Influenza Season in the United States

Clin Infect Dis

Boikos C, Fischer L, O'Brien D, Vasey J, Sylvester GC, Mansi JA

doi: 10.1093/cid/ciaa1944

Viral Infections, Non-HIV

The impact of repeated vaccination on influenza vaccine effectiveness: a systematic review and meta-analysis

BMC Med.

Ramsay LC, Buchan SA, Stirling RG, Cowling BJ, Feng S, Kwong JC, Warshawsky BF

doi: 10.1186/s12916-018-1239-8.

Viral Infections, Non-HIV

Influenza vaccine effectiveness in older adults compared with younger adults over five seasons

Vaccine.

Russell K, Chung JR, Monto AS, Martin ET, Belongia EA, McLean HQ, Gaglani M, Murthy K, Zimmerman RK, Nowalk MP, Jackson ML, Jackson LA, Flannery B

doi: 10.1016/j.vaccine.2018.01.045.

Viral Infections, Non-HIV

Insights into the protective effects of influenza vaccination: More hospitalizations but lower follow-up mortality during the 2014/15 influenza season in a Swiss cohort

Vaccine.

Ulyte A, Wei W, Gruebner O, Bähler C, Brüngger B, Blozik E, Dressel H, Schwenkglenks M, von Wyl V

doi: 10.1016/j.vaccine.2020.06.019.

Viral Infections, Non-HIV

Predominance of influenza virus A(H3N2) 3C.2a1b and A(H1N1)pdm09 6B.1A5A genetic subclades in the WHO European Region, 2018-2019

Vaccine.

Melidou A, Hungnes O, Pereyaslov D, Adlhoch C, Segaloff H, Robesyn E, Penttinen P, Olsen SJ, European Region influenza surveillance network.

doi: 10.1016/j.vaccine.2020.06.031.

Viral Infections, Non-HIV

Vaccine effectiveness against laboratory-confirmed influenza in Europe - Results from the DRIVE network during season 2018/19

Vaccine.

Stuurman AL, Bollaerts K, Alexandridou M, Biccler J, Díez Domingo J, Nohynek H, Rizzo C, Turunen T, Riera-Montes M, DRIVE Public Partners.

doi: 10.1016/j.vaccine.2020.07.063.

Viral Infections, Non-HIV

Repeated influenza vaccination for preventing severe and fatal influenza infection in older adults: a multicentre case-control study

CMAJ.

Casado I, Domínguez Á, Toledo D, Chamorro J, Astray J, Egurrola M, Fernández-Sierra MA, Martín V, Morales-Suárez-Varela M, Godoy P, Castilla J; Project PI12/02079 Working Group

doi: 10.1503/cmaj.170910.

Efficacy, immunogenicity, and safety of a quadrivalent inactivated influenza vaccine in children aged 6-35 months: A multi-season randomised placebo-controlled trial in the Northern and Southern Hemispheres

Vaccine.

Pepin S, Dupuy M, Borja-Tabora CFC, Montellano M, Bravo L, Santos J, de Castro JA, Rivera-Medina DM, Cutland C, Ariza M, Diez-Domingo J, Gonzalez CD, Martinón-Torres F, Papadopoulou-Alataki E, Theodoriadou M, Kazek-Duret MP, Gurunathan S, De Bruijn I; GQM05 Study Group

doi: 10.1016/j.vaccine.

Related content

Influenza vaccine effectiveness against hospitalization with laboratory-confirmed influenza in Greece: A pooled analysis across six seasons, 2013-2014 to 2018-2019

Relative Effectiveness of the Cell-Derived Inactivated Quadrivalent Influenza Vaccine Versus Egg-Derived Inactivated Quadrivalent Influenza Vaccines in Preventing Influenza-Related Medical Encounters During the 2018-2019 Influenza Season in the United States

The impact of repeated vaccination on influenza vaccine effectiveness: a systematic review and meta-analysis

Influenza vaccine effectiveness in older adults compared with younger adults over five seasons

Insights into the protective effects of influenza vaccination: More hospitalizations but lower follow-up mortality during the 2014/15 influenza season in a Swiss cohort

Predominance of influenza virus A(H3N2) 3C.2a1b and A(H1N1)pdm09 6B.1A5A genetic subclades in the WHO European Region, 2018-2019

Vaccine effectiveness against laboratory-confirmed influenza in Europe - Results from the DRIVE network during season 2018/19

Repeated influenza vaccination for preventing severe and fatal influenza infection in older adults: a multicentre case-control study

Efficacy, immunogenicity, and safety of a quadrivalent inactivated influenza vaccine in children aged 6-35 months: A multi-season randomised placebo-controlled trial in the Northern and Southern Hemispheres

Efficacy, immunogenicity, and safety of a quadrivalent inactivated influenza vaccine in children aged 6-35 months: A multi-season randomised placebo-controlled trial in the Northern and Southern Hemispheres